Evidence map›Paper›PMID 30670876›Full record

ArticleNature medicine2019

Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors.

Pakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, Franziska Loebel, Xiuyu Cui, S Harrison Farber, Karolina Woroniecka, Aladine A Elsamadicy, Cosette A Dechant, Hanna R Kemeny and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial.Clinical cancer research : an official journal of the American Association for Cancer Research · 2020
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. [Basis of Tumor Microenvironment Relevant to Immunotherapies for Brain Metastases of NSCLC].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2019
    Review
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Pakawat ChongsathidkietPreston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.ORCID http://orcid.org/0000-0001-5363-3061
Christina JacksonDepartment of Neurosurgery, The John Hopkins University School of Medicine, Baltimore, MD, USA.
Shohei KoyamaDepartment of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita City, Osaka, Japan.ORCID http://orcid.org/0000-0002-6897-9417
Franziska LoebelDepartment of Neurosurgery, Charité Medical University, Berlin, Germany.
Xiuyu CuiPreston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.
S Harrison FarberPreston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.ORCID http://orcid.org/0000-0002-0171-6516
Karolina WoronieckaPreston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.
Aladine A ElsamadicyPreston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.
Cosette A DechantPreston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.
Hanna R KemenyPreston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.
Luis Sanchez-PerezPreston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.
Tooba A CheemaUnum Therapeutics, Cambridge, MA, USA.
Nicholas C SoudersDana-Farber Cancer Institute, Boston, MA, USA.
James E HerndonDepartment of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA.
Jean-Valery CoumansDepartment of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Jeffrey I EverittDepartment of Pathology, Duke University Medical Center, Durham, NC, USA.
Brian V NahedDepartment of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
John H SampsonPreston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA.
Michael D GunnDepartment of Pathology, Duke University Medical Center, Durham, NC, USA.ORCID http://orcid.org/0000-0003-4602-0667
Robert L MartuzaDepartment of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Glenn DranoffNovartis Institutes for Biomedical Research, Cambridge, MA, USA.
William T CurryDepartment of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Peter E FecciPreston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA. peter.fecci@duke.edu.

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
A Novel Clinical Challenge in Brain Tumor Immunology: T cell SequestrationR01NS099096 · NINDS · DUKE UNIVERSITY · PI FECCI, PETER · 2017 to 2021
$1.7M
NIGMS NIH HHS T32 GM007171NINDS NIH HHS R01 NS099096
6 · The paper itself

Abstract

In the version of this article originally published, the figure callout in this sentence was incorrect: "Furthermore, in S1P1-KI mice themselves, whereas PD-1 blockade was ineffectual as monotherapy, the effects of 4-1BB agonism and checkpoint blockade proved additive, with the combination prolonging median survival and producing a 50% long-term survival rate (Fig. 6f)." The callout should have been to Supplementary Fig. 6b. The error has been corrected in the PDF and HTML versions of the article.

Identifiers

PMID30670876
PMCPMC6825406

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.